Title: Cancer nanomedicine: progress, challenges and opportunities
First-pass extracted concept
cancer nanomedicine
Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s
Evidence Snippets
Supporting Sources
Linked Claims
The topic scope includes exemplar nanomedicine modalities already used or tested clinically, including albumin-bound paclitaxel.
Quoted textsource-backed
The anchor article is a 2017 Nature Reviews Cancer review on cancer nanomedicine that emphasizes three recurring enrichment themes ... (3) exemplar nanomedicine modalities already used or tested clinically, such as albumin-bound paclitaxel.
The anchor review emphasizes biological delivery constraints in tumors, especially the enhanced permeability and retention framework and its limitations.
Quoted textsource-backed
The anchor article is a 2017 Nature Reviews Cancer review on cancer nanomedicine that emphasizes three recurring enrichment themes also strongly represented in the surrounding literature: (1) biological delivery constraints in tumors, especially the enhanced permeability and retention (EPR) framework and its limitations
The review addresses progress, challenges, and opportunities in cancer nanomedicine.
Quoted textsource-backed
Cancer nanomedicine: progress, challenges and opportunities
The anchor review emphasizes translational and clinical-manufacturing barriers in cancer nanomedicine.
Quoted textsource-backed
The anchor article is a 2017 Nature Reviews Cancer review on cancer nanomedicine that emphasizes three recurring enrichment themes also strongly represented in the surrounding literature: ... (2) translational and clinical-manufacturing barriers